Nav: Home

Gene mutation and use of certain antidepressants may decrease effects of breast cancer drug

June 05, 2004

Researchers from the Johns Hopkins Kimmel Cancer Center, Indiana University and the University of Michigan have found that some women have a gene mutation that may decrease the effectiveness of tamoxifen, a commonly used breast cancer drug. The findings, to be reported at the 40th annual meeting of the American Society of Clinical Oncology on June 5, may tell physicians which women might have reduced benefit from tamoxifen therapy. Results also suggest that some frequently prescribed antidepressants may reduce tamoxifen's effects because the antidepressants affect a similar metabolic pathway.

Although a test for the mutation in the CYP2D6 gene is not widely available, the investigators recommend that women currently on long-term tamoxifen therapy and using such antidepressants as paroxetine and sertraline consult their health care provider for guidance. These drugs, known as selective serotonin reuptake inhibitors (SSRIs) include such well-known brands as Paxil and Zoloft. The investigators estimate the prevalence of the CYP2D6 mutation to be approximately 40 percent, and in this study of 80 women, 35 percent had the mutation.

"There's no evidence from this study that a woman who is taking tamoxifen should automatically stop using a particular antidepressant if it is helping her," says Vered Stearns, M.D., assistant professor of oncology at the Johns Hopkins Kimmel Cancer Center. But the researchers advise that women on tamoxifen who are considering antidepressant therapy, may opt to use an antidepressant, such as venlafaxine, which may not alter tamoxifen's metabolism and has less of an effect on tamoxifen.

"Our findings are leading us in the direction of recommending therapies based on an individual's genetic profile," says Stearns. "If a woman has a particular gene mutation, we may be able to predict how she'll react to a therapy."

Tamoxifen is widely prescribed to reduce the risk of breast cancer recurrence or spread and increasingly is given in efforts to prevent breast cancer in women at high risk for the disease.

The CYP2D6 gene controls production of an enzyme that breaks down and processes tamoxifen. Mutations in the gene reduce the enzyme's ability to properly break down tamoxifen.

The women in the study had taken tamoxifen daily for four months. Analysis of blood levels of a newly characterized byproduct, called endoxifen, were approximately 75 percent lower in women with a CYP2D6 mutation in both copies of the gene. The lower levels of endoxifen suggest that mutation alters the metabolism of tamoxifen and may affect potency of the drug.

"At this point, we do not know precisely what lower levels of endoxifen signify, or if other byproducts of tamoxifen metabolism are equally or more important to measure for monitoring tamoxifen's effectiveness," cautions Stearns.

The investigators also found lower endoxifen levels in women taking antidepressant drugs regardless of whether or not they had a CYP2D6 gene mutation. Certain antidepressant drugs, such as paroxetine and sertraline, are known to block the CYP2D6 enzyme. Antidepressants are being prescribed in up to 20 percent of breast cancer patients for depression, anxiety, other psychiatric disorders or hot flashes, a common side effect of tamoxifen.

In upcoming studies, the investigators will compare antidepressant therapies in women taking tamoxifen and how gene variations in the estrogen receptors of breast cancer patients may impact the effectiveness of tamoxifen.
This research was funded by the National Institutes of Health (NIH/NIGMS).

Additional participants in this research were Yan Jin, Bryan Ward, Todd Skaar, Anna Maria Storniolo, Anne Nguyen, Zeruesenay Desta and David A. Flockhard from Indiana University School of Medicine; and Linda Ullmer, Jill Hayden and Daniel F. Hayes from the University of Michigan.

Abstract #508, Proceeding of the American Society of Clinical Oncology, 2004.

Johns Hopkins Kimmel Cancer Center:

Johns Hopkins Medicine

Related Antidepressants Articles:

Antidepressants reduce deaths by more than a third in patients with diabetes
Antidepressants reduce deaths by more than a third in patients with diabetes and depression, according to a study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.
Antidepressants can reduce the empathic empathy
Depression is a disorder that often comes along with strong impairments of social functioning.
Possible link between autism and antidepressants use during pregnancy
An international team led by Duke-NUS Medical School has found a potential link between autistic-like behaviour in adult mice and exposure to a common antidepressant in the womb.
When neurons are out of shape, antidepressants may not work
Selective serotonin reuptake inhibitors (SSRIs) are the most commonly prescribed medication for major depressive disorder (MDD), yet scientists still do not understand why the treatment does not work in nearly thirty percent of patients with MDD.
Next-generation metabolomics may facilitate the discovery of new antidepressants
Antidepressants have become one of the most commonly prescribed drugs.
Male birds sing less to females on antidepressants
Female starlings who have ingested dilute concentrations of antidepressants while feeding on worms, maggots and flies at sewage treatment plants appear to be less attractive to the opposite sex.
Depression and antidepressants are associated with an increased risk of VTE
In the first review of its kind, new research has found that depression and the use of antidepressants are each associated with an increased risk of venous thromboembolism (VTE).
Algorithm identifies patients best suited for antidepressants
Results of a new study bring us closer to identifying individuals likely to benefit from antidepressants.
OHSU research provides new insight about antidepressants
New molecular research shows how chemically diverse drugs used to treat depression and anxiety disorders interact with the protein that transports serotonin in the brain.
New study on the placebo effect and antidepressants in children and adolescents
Although the clinical efficacy of antidepressants in children and adolescents is proven, it is frequently accompanied by side effects.
More Antidepressants News and Antidepressants Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.